5 Amendments of Anna ROSBACH related to 2011/2220(DEC)
Amendment 3 #
Draft opinion
Paragraph 5
Paragraph 5
5. Has already addressed the problematic ofNotes that concerns remain over the institutional failings that led to high carry- overs, doubts over the propriety of the subsequent professional activities of the former Executive Director, the missing Declarations of Interests by a number of experts involved in the evaluation of medicinal products also mentioned in the Internal Audit Service follow-up report and the overdue decision by the Management Board to reform the payment system for services provided by Member States' authorities in its first opinion to the responsible committee; is of the opinion that EMA has already made significant efforts to strengthen its internal procedures to assure the independence of its experts andrequests that the European Parliament its staff and has asked to be informed twice a year about the improved implementation of theremedial measures that are being taken in this regard;
Amendment 8 #
Draft opinion
Paragraph 6
Paragraph 6
6. Points out again that the Court of Auditors made observations on carryovers, IT contracts and the payment system for services provided by national authorities but despite these inconsistencies, considered the Agency's accounts of 2010 reliable, legal and regular;
Amendment 9 #
Draft opinion
Paragraph 8
Paragraph 8
8. Welcomes, in general, the agreement on the Joint Statement and the Common Approach of the European Parliament, the Council and the Commission on decentralised agencies; recalls that certain elements of importance to the discharge have been addressed and taken up; believstresses that the roadmap on the follow-up to the Common Approach willmust duly take dueinto account of those issues;
Amendment 11 #
Draft opinion
Paragraph 9
Paragraph 9
9. Believes that the discharge decision for the EMA cannotshould be based upon additional requirements, e.g. OECD guidelines, when the implementation of those requirements have neither been officially asked for by the EU legislator nor by specific arrangements within the Agencies during the respective discharge procedureOECD guidelines to ensure high quality internationally recognised accounting, audit and financial disclosure standards; invites the European institutions to examine whether it is advisable to incorporate and to commit to additionalintroducing OECD guidelines within a possible commoncommon working framework for all European institutions and bodies;
Amendment 13 #
Draft opinion
Paragraph 10
Paragraph 10
10. Is of the opinion that, on the basis of the information available, discharge canshould not be granted to the Executive Director of the European Medicines Agency in respect of the implementation of the Agency's budget for the financial year 2010.